Study Assessing the Effectiveness of a Cardiac Web-based eLearning Platform

Coronary Artery Disease Clinical Trial

— eEduHeart I  

Official title:

eEduHeart I: a Multi-center Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-based eLearning Platform

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02475967
• Other study ID #: PDEN-IFRE 01
• Status: Completed
• Phase: N/A
• First received: June 10, 2015
• Last updated: February 26, 2018
• Start date: January 2016
• Est. completion date: February 2018

Study information

• Verified date: February 2018
• Source: Hasselt University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In the trial cardiac patients will be provided with unrestricted access to the web-based eLearing platform for a one-month period.

Description:

Patients participating in the trial will be provided with a cardiac web-based eLearning platform for one month during study period. The medical content of the packages will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists).

E-Learning packages type I: videos with information from caregivers. In these videos, medics and paramedics are interviewed to highlight the etiology, pathophysiology and treatment of coronary artery disease; the associated comorbidities and the ways to prevent recurrence.

E-Learning packages type II: videos in which patients are interviewed. Patients can help each other to adhere to their treatment plan, by sharing stories from their own experience about their illness and the rehabilitation afterwards. Short clips of maximum 2 minutes will be provided to study participants.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: February 2018
• Est. primary completion date: February 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients suffering from coronary artery disease for which they are treated conservatively, with a percutaneous coronary intervention or with coronary artery bypass grafting

Exclusion Criteria:

• Patients with dementia or cognitive impairment not being able to sufficiently understand the E-Learning packages content

• (Foreign) patients unable to speak Dutch, thereby not being able to understand the content of the E-Learning packages

• Patients with advanced visual and/or auditory impairments, hindering them to adequately understand the E-earning packages

• Patients participating in another trial during the Pilot study period

• Patients refusing to provide signed consent

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia

Intervention

Other:
• Intervention group
The intervention group patients have access to the eLearning platform in addition to conventional cardiac care.The content of platform will be gathered from a multidisciplinary input of both medics (e.g. cardiologists) and paramedics (e.g. psychologists). Patients will also contribute to platform content.
• Control group
The control group patients receive conventional cardiac care alone.

Locations

Country	Name	City	State
Belgium	ZOL	Genk
Belgium	Jessa Ziekenhuis	Hasselt

Sponsors (2)

Lead Sponsor	Collaborator
Hasselt University	Jessa Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health-related quality of life	Health-related quality of life, assessed by HeartQol	3 months
Secondary	Adherence to the E-learning packages	Adherence to the E-learning packages as assessed by the number of logs and the cumulative log time on the E-learning platform per patient.	3 months
Secondary	Effectiveness of E-learning packages	Effectiveness of intervention in improving patients' knowledge of cardiac diseases as assessed by questionnaire scores.	3 months
Secondary	User experience of eLearning platform	Asses user experience of eLearning platform by User Experience Questionnaire (UEQ)	3 months